The Patent Finder

Incanthera Ltd

Also on record
Records under this name other than patents Incanthera Ltd holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Incanthera Ltd

PatentTitleStatus Expires Confidence
US 9,956,296Compounds containing a vascular disrupting agent
Formerly held
Lapsed on the fee record
Ended May 1, 2026 · From the USPTO record
Lapsed on the fee recordEnded May 1, 2026From the USPTO record
US 9,937,267Methods of treating cancer using compounds containing a vascular disrupting agent
Formerly held
Lapsed on the fee record
Ended Apr 10, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 10, 2026From the USPTO record
US 8,691,751Compounds containing a vascular disrupting agent
Formerly held
Lapsed on the fee record
Ended Apr 8, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 8, 2026From the USPTO record
US 10,912,839Methods of treating cancer using compounds containing a vascular disrupting agent
Formerly held
Lapsed on the fee record
Ended Feb 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 9, 2025From the USPTO record
US 9,358,303Compounds containing a vascular disrupting agent
Formerly held
Lapsed on the fee record
Ended Jun 7, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 7, 2024From the USPTO record
US 10,556,014Compounds containing a vascular disrupting agent
Formerly held
Lapsed on the fee record
Ended Feb 11, 2024 · From the USPTO record
Lapsed on the fee recordEnded Feb 11, 2024From the USPTO record
US 7,192,977Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment
Term ended
Term ended May 8, 2023 · From the USPTO record
Term endedTerm ended May 8, 2023From the USPTO record
US 10,201,622Tumour-targeted theranostic
Formerly held
Lapsed on the fee record
Ended Feb 12, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 12, 2023From the USPTO record
US 8,927,486Compounds
Formerly held
Lapsed on the fee record
Ended Jan 6, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jan 6, 2023From the USPTO record
US 7,626,026Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
Lapsed on the fee record
Ended Dec 1, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 1, 2021From the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited